DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,835,000 | +671.0% | 49,160 | +429.1% | 0.21% | +428.2% |
Q1 2021 | $238,000 | -45.2% | 9,291 | -52.8% | 0.04% | -45.1% |
Q4 2020 | $434,000 | -1.1% | 19,688 | -19.3% | 0.07% | -2.7% |
Q3 2020 | $439,000 | +133.5% | 24,388 | +138.5% | 0.07% | +55.3% |
Q1 2020 | $188,000 | -84.8% | 10,225 | -81.8% | 0.05% | -67.4% |
Q4 2019 | $1,238,000 | – | 56,189 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |